| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2022 | Sep 21, 2022 | Aptose Biosciences Inc. | SR VP & Chief Fin. Officer | Buy | 90.0 | +10,000 | 100.00% | ✗ | $6.8K |
| Dec 17, 2015 | Dec 18, 2015 | GYRE THERAPEUTICS, INC. | CFO | Buy | 91.3 | +10,000 | 66.52% | ✗ | $20K |